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Women With Chest Pain*
Expanding the Diagnostic Armamentarium
Joseph Selvanayagam, MBBS (HONS), DPHIL
Adelaide, AustraliaThere is now strong evidence that coronary artery
disease (CAD) clinical outcomes are worse in
women when compared with men, irrespective of
age (1). This disparity is accounted for, at least in
part, by the gender bias in the use of investigations
and evidence-based medical therapy in CAD, lead-
ing to women presenting with more advanced
disease (2). The assessment of CAD in women
often presents a challenge because of the greater and
atypical symptom burden and much lower preva-
lence of obstructive coronary artery disease com-
pared with men (3).
Currently well-established noninvasive tests for
the diagnosis of coronary artery disease—exercise
electrocardiography (ECG), stress echocardiogra-
phy, and stress single-photon emission computed
tomography (SPECT)—all have substantial
limitations in women in predicting significant
See page 436
angiographic CAD. Exercise ECG, which is the
most commonly performed noninvasive initial in-
vestigation for the diagnosis of stable angina, has a
particular disadvantage of being poorly specific for
obstructive CAD in women. Reported specificities
(with regard to the presence of obstructive epicar-
dial CAD) have ranged from 30% to 70%, which
are much lower than the reported rates in men
(4,5). SPECT imaging, with either exercise or
pharmacological stress, is commonly used for the
evaluation of women presenting with chest pain
symptoms. Although experience with these tech-
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Department of Cardiovascular Medicine, Flinders University of
South Australia, Adelaide, Australia.niques is extensive (6,7), diagnostic accuracy can be
reduced in women by both breast tissue and obesity,
causing false-positive results, especially in the ante-
rior myocardial segments. In contrast, stress echo-
cardiography has performed better, possibly as the
result of selection bias. Three meta-analyses have
reported specificities ranging from 76% to 79% and
sensitivities ranging from 81% to 86% for stress
echocardiography (6), although both exercise and
pharmacological stress echocardiography remain
principally limited by acoustic windows and the
difficulty in detecting minor gradations of wall
motion change, particularly in the setting of abnor-
mal resting function.
During the last 15 years, cardiac magnetic reso-
nance imaging (CMR) has emerged as an attractive
noninvasive approach for the assessment of CAD/
chest pain syndromes, offering spatial resolution
superior to nuclear techniques without the use of
ionizing radiation (8). Previous studies, mainly in
men, evaluating the utility of perfusion CMR in
assessing CAD have found moderate-to-high diag-
nostic accuracy (9,10). Diagnostic accuracy has been
further augmented by the use of a higher field
strength (increased signal to noise ratio, increased
sensitivity) (11) and by the combination of perfu-
sion with late gadolinium enhancement (reduced
misreads due to artefact, increased specificity) (12).
In this issue of i JACC ( JACC: Cardiovascular Im-
aging), the article by Klem et al. (13) is the first to
address the utility of CMR perfusion and late
enhancement exclusively in women. In this pro-
spective observational study, researchers enrolled
147 consecutive women with chest pain or other
symptoms that were suggestive of CAD. The 1.5-T
CMR assessment consisted both of adenosine-
stress and rest perfusion, and delayed enhancement
imaging. The CMR components were analyzed
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447isually with a pre-specified algorithm that the
uthors had previously described (12).
So how did CMR perform in this difficult patient
roup? The authors’ principle finding is that the
ombined CMR stress test had a sensitivity of 84%,
pecificity of 88%, with an overall diagnostic accuracy
f 87% for the diagnosis of significant CAD, as
efined by 70% stenosis on quantitative coronary
ngiography. Reflecting the nuclear cardiology litera-
ure, test sensitivity was reduced in women with
ingle-vessel disease (71% vs. 100% compared with
ultivessel disease) and small left ventricular mass
69% vs. 95%). Although the specificity of the com-
ined CMR stress test reported by Klem et al. (13)
ompares favorably with the specificities published in
eta-analyses for exercise ECG, stress echocardiog-
aphy, and stress SPECT; such comparisons are dif-
cult to make because the inclusion criteria differ
cross studies, and all of them (including that of Klem
t al.) suffer from significant selection bias. More
irect-comparison studies of noninvasive modalities
in the same population) are needed.
A number of intriguing and unanswered ques-
ions have emerged from this study. Although
Figure 1. Proposed Algorithm for the Evaluation of Women Wit
BOLD  blood oxygenation level dependent magnetic resonance im
ing; SPECT  single-photon emission computer tomography.ommonly used as the standard of reference in such
tudies, quantitative coronary angiography is not
he ideal gold standard because the functional
ignificance of coronary obstruction and luminal
tenosis are only moderately correlated. Hence, it
ould have been useful to know the relationship
etween the result of the initial noninvasive test
whether it be exercise ECG, stress echo, or stress
PECT) and the subsequent CMR perfusion finding.
Was there good concordance between the func-
ional tests in these women? The authors do not
rovide complete information on the baseline and
MR characteristics of the patients with “false-
ositive” and “false-negative” findings. Clearly, cor-
nary microvascular disease due to diabetes, hyper-
ension, or cardiac syndrome X could account for
ome of the “false-positives” reported in this study.
t would have been useful to know whether women
ith clinical features suggestive of cardiac syndrome
always had perfusion abnormalities evident visu-
lly or whether some of them had visually normal
erfusion CMR. Although syndrome X has tradi-
ionally been viewed as giving rise to global suben-
ocardial perfusion defect under stress (14), recent
hest Pain
ing; ECG  electrocardiography; MRI  magnetic resonance imag-h C
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448MR literature on this has been contradictory
15,16).
Finally, what other imaging tools do we have
o tease out the varied and disparate causes of
hest pain in women? In some women without
bstructive CAD, chest pain symptoms may be
econdary to the coronary slow flow phenomenon
17) or related to metabolic abnormalities, result-
ng in a shift toward myocardial glucose metab-
lism. Cardiac magnetic resonance imaging spec-
roscopy has been used to identify alterations in
igh-energy phosphates, providing a direct as-
essment of metabolic myocardial ischemia. A
ecent prognostic report from the WISE (Wom-
n’s Ischemia Syndrome Evaluation) study sug-
ested that chest pain hospitalizations were
reater in women with a reduced phosphocre-
tine/adenosine triphosphate ratio (20%) and
onobstructive coronary arteries (18). Although
ffering interesting pathophysiological insights,
MR spectroscopy at 1.5-T remains limited by
ow spatial resolution, poor interstudy reproduc-
bility, and limited availability. Both quantitative
MR perfusion imaging (19) and blood oxygen
evel-dependent magnetic resonance imaging
20) might offer diagnostic and mechanistic in-
ights. Blood oxygen level-dependent magnetic
esonance imaging is the only noninvasive imag-
ng modality that currently has the potential to
easure myocardial oxygenation directly in hu-
ans. It is more robust at a higher field strengthison of the sensitivity and specificity
of exercise electrocardiography in bi-
tion of coronary art
lation 2003;108:432usion, might allow the interrogation of suben-
ocardial versus subepicardial ischemia, especially
n the cohort of women with chest pain and
ormal coronary arteries. A number of catheter-
zation laboratory-based assessment methods also
re available, including techniques to assess cor-
nary endothelial dysfunction and/or coronary
icrocirculation (intracoronary flow wire mea-
urements, intracoronary acetylcholine), although
heir invasive nature precludes widespread appli-
ability. Figure 1 outlines a proposed diagnostic
lgorithm for the evaluation of women symptom-
tic with chest pain.
The benefits of noninvasive testing are greatest in
atients with an intermediate-to-high pre-test like-
ihood of CAD, that is, the population that was
ainly addressed by Klem et al. (13). Patients with
ntermediate risk who have a negative test are
nlikely to have coronary disease and usually do not
equire further testing. Although more work needs
o be performed, particularly in women with chest
ain and normal coronary arteries, this study by
lem et al. (13) is an important step in bridging the
ender gap in the performance of diagnostic proce-
ures for the investigation of CAD.
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